Logo image of ERF.PA

EUROFINS SCIENTIFIC (ERF.PA) Stock Price, Quote, News and Overview

EPA:ERF - Euronext Paris - Matif - FR0014000MR3 - Common Stock - Currency: EUR

51  -0.12 (-0.23%)

ERF.PA Quote, Performance and Key Statistics

EUROFINS SCIENTIFIC

EPA:ERF (2/7/2025, 7:00:00 PM)

51

-0.12 (-0.23%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High62.1
52 Week Low39.47
Market Cap9.84B
Shares192.98M
Float128.21M
Yearly Dividend1
Dividend Yield0.98%
PE16.61
Fwd PE14.49
Earnings (Next)04-23 2025-04-23
IPO10-24 1997-10-24


ERF.PA short term performance overview.The bars show the price performance of ERF.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10

ERF.PA long term performance overview.The bars show the price performance of ERF.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of ERF.PA is 51 EUR. In the past month the price increased by 3.93%. In the past year, price decreased by -5.83%.

EUROFINS SCIENTIFIC / ERF Daily stock chart

ERF.PA Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TN8.DE THERMO FISHER SCIENTIFIC INC 26.03 210.11B
DAP.DE DANAHER CORP 27.77 145.03B
56S1.DE SARTORIUS STEDIM BIOTECH 67.59 20.98B
DIM.PA SARTORIUS STEDIM BIOTECH 66.3 20.59B
SRT3.DE SARTORIUS AG-VORZUG 50.85 18.81B
ILU.DE ILLUMINA INC 65.04 17.23B
SRT.DE SARTORIUS AG 40.4 14.95B
ESF0.DE EUROFINS SCIENTIFIC 16.6 9.83B
QIA.DE QIAGEN N.V. 19.25 8.81B
1SXP.DE SCHOTT PHARMA AG& CO KGAA 24.3 3.62B
EVT.DE EVOTEC SE N/A 3.08B
GXI.DE GERRESHEIMER AG 17.37 2.74B

About ERF.PA

Company Profile

ERF logo image Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. The company operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.

Company Info

EUROFINS SCIENTIFIC

23 Val Fleuri

Luxembourg LU

Employees: 61798

Company Website: https://www.eurofins.com/

Investor Relations: https://www.eurofins.com/investors

Phone: 35226185320

ERF.PA FAQ

What is the stock price of ERF.PA?

The current stock price of ERF.PA is 51 EUR.


What is the symbol for EUROFINS SCIENTIFIC stock?

The exchange symbol of EUROFINS SCIENTIFIC is ERF and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ERF.PA stock listed?

ERF.PA stock is listed on the Euronext Paris - Matif exchange.


Is ERF.PA a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ERF.PA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ERF.PA.


Does ERF.PA stock pay dividends?

ERF.PA has a dividend yield of 0.98%. The yearly dividend amount is currently 1.


When does ERF.PA stock report earnings?

ERF.PA will report earnings on 2025-04-23.


What is the Price/Earnings (PE) ratio of ERF.PA?

The PE ratio for ERF.PA is 16.61. This is based on the reported non-GAAP earnings per share of 3.07 and the current share price of 51 EUR.


ERF.PA Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to ERF.PA. When comparing the yearly performance of all stocks, ERF.PA is a bad performer in the overall market: 64.11% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ERF.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to ERF.PA. Both the profitability and the financial health of ERF.PA get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ERF.PA Financial Highlights

Over the last trailing twelve months ERF.PA reported a non-GAAP Earnings per Share(EPS) of 3.07. The EPS increased by 140% compared to the year before.


Industry RankSector Rank
PM (TTM) 5.79%
ROA 5.51%
ROE 11.24%
Debt/Equity 0.59
Chartmill High Growth Momentum
EPS Q2Q%215.46%
Sales Q2Q%110.31%
EPS 1Y (TTM)140%
Revenue 1Y (TTM)59.18%

ERF.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 56% to ERF.PA. The Buy consensus is the average rating of analysts ratings from 22 analysts.

For the next year, analysts expect an EPS growth of 13.2% and a revenue growth 7.58% for ERF.PA


Ownership
Inst Owners37.01%
Ins Owners0%
Short Float %N/A
Short RatioN/A
Analysts
Analysts56.36
Price Target57.75 (13.24%)
EPS Next Y13.2%
Revenue Next Year7.58%